Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2010 - 2026)

Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 37.35 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 4.00 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 3.72 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 13.52 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 1.84 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 49,000.00
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 2.53 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 90.90 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 1.40 Bn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 232.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 90.90 Mn
Mar 31, 2026 90.90 Mn
Dec 31, 2025 89.80 Mn
Dec 31, 2025 89.80 Mn
Sep 30, 2025 97.30 Mn
Sep 30, 2025 97.30 Mn
Jun 30, 2025 91.70 Mn
Jun 30, 2025 91.70 Mn
Mar 31, 2025 87.00 Mn
Mar 31, 2025 87.00 Mn
Dec 31, 2024 82.60 Mn
Dec 31, 2024 82.60 Mn
Sep 30, 2024 80.00 Mn
Sep 30, 2024 80.00 Mn
Jun 30, 2024 80.10 Mn
Jun 30, 2024 80.10 Mn
Mar 31, 2024 75.30 Mn
Mar 31, 2024 75.30 Mn
Dec 31, 2023 70.80 Mn
Dec 31, 2023 70.80 Mn